Health Care & Life Sciences » Pharmaceuticals | Otsuka Holdings Co. Ltd.

Otsuka Holdings Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
573,272
460,619
369,875
336,613
285,022
Total Accounts Receivable
326,698
387,842
367,574
375,373
387,746
Inventories
151,862
135,846
133,758
144,538
157,128
Other Current Assets
117,009
153,667
242,645
154,415
103,203
Total Current Assets
1,168,841
1,140,580
1,113,855
1,010,942
933,102
Net Property, Plant & Equipment
315,185
359,561
358,762
382,462
393,572
Total Investments and Advances
303,776
175,762
166,600
364,338
344,786
Long-Term Note Receivable
5,260
-
-
-
-
Intangible Assets
192,263
725,953
678,813
705,325
768,039
Other Assets
26,136
163,861
153,316
10,206
8,704
Total Assets
2,028,399
2,575,280
2,478,290
2,480,256
2,476,634
ST Debt & Current Portion LT Debt
55,842
82,801
81,390
66,489
Accounts Payable
132,900
82,008
86,795
85,399
Income Tax Payable
51,064
18,961
21,482
8,036
Other Current Liabilities
197,614
296,266
246,946
226,541
Total Current Liabilities
437,420
480,036
436,613
386,465
Long-Term Debt
20,076
239,853
198,881
183,253
Provision for Risks & Charges
10,718
31,638
15,835
18,427
Deferred Taxes
280
73,931
63,325
37,705
Other Liabilities
11,227
12,889
18,252
25,473
Total Liabilities
496,099
847,907
739,845
658,303
Common Equity (Total)
1,484,674
1,698,464
1,710,531
1,793,278
Total Shareholders' Equity
1,484,674
1,698,464
1,710,531
1,793,278
Total Equity
1,510,759
1,727,370
1,738,441
1,821,949
Liabilities & Shareholders' Equity
2,028,399
2,575,277
2,478,286
2,480,252
Accumulated Minority Interest
26,085
28,906
27,910
28,671
Non-Equity Reserves
21,541
-
-
-

About Otsuka Holdings Co.

View Profile
Address
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
Employees -
Website http://www.otsuka.com
Updated 07/08/2019
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases.